Merck & Co., Inc. (BMV:MRK)

Mexico flag Mexico · Delayed Price · Currency is MXN
1,612.00
+4.24 (0.26%)
Last updated: Oct 30, 2025, 9:40 AM CST
0.26%
Market Cap3.99T
Revenue (ttm)1.18T
Net Income (ttm)349.13B
Shares Outn/a
EPS (ttm)138.59
PE Ratio11.42
Forward PE9.41
Dividend62.69 (3.89%)
Ex-Dividend DateSep 15, 2025
Volumen/a
Average Volume2,530
Open1,569.99
Previous Close1,607.76
Day's Range1,569.99 - 1,612.00
52-Week Range1,425.00 - 2,150.00
Beta0.37
RSI54.01
Earnings DateOct 30, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.